Clinical Trial

AV-23-001 AVAVA MIRIA Pilot Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural irregularities, or scars). The study is also intended to assist in determination of the optimal laser configuration and treatment parameters that most consistently yield results.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-13; most recent amendment 2025-03-05.
Status change: Recruiting → Active, Not Recruiting 2025-03-05
Trial Details
NCT Number NCT06557434
Lead Sponsor AVAVA, Inc.
Conditions Wrinkle, Acne Scars - Mixed Atrophic and Hypertrophic, Pigmented Lesions, Skin Laxity, Scars
Enrollment 200 participants
Start Date 2023-11-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-07